Detailed information for compound 40751

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 425.037 | Formula: C15H9BrCl2NNaO3
  • H donors: 1 H acceptors: 3 LogP: 5.19 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: [O-]C(=O)Cc1cc(Cl)cc(c1N)C(=O)c1ccc(cc1Cl)Br.[Na+]
  • InChi: 1S/C15H10BrCl2NO3.Na/c16-8-1-2-10(12(18)5-8)15(22)11-6-9(17)3-7(14(11)19)4-13(20)21;/h1-3,5-6H,4,19H2,(H,20,21);/q;+1/p-1
  • InChiKey: JOAUIYGOIKPNGA-UHFFFAOYSA-M  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Bos taurus Cyclooxygenase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) animal heme peroxidase 0.0095 0.5 0.5
Loa Loa (eye worm) blistered cuticle protein 3 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Onchocerca volvulus 0.0095 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Onchocerca volvulus Peroxidasin homolog 0.0095 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Loa Loa (eye worm) animal heme peroxidase 0.0095 0.5 0.5
Onchocerca volvulus Peroxidasin homolog 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Onchocerca volvulus 0.0095 0.5 0.5
Loa Loa (eye worm) animal heme peroxidase 0.0095 0.5 0.5
Onchocerca volvulus Dual oxidase homolog 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Schistosoma mansoni peroxidasin 0.0095 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0095 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0095 0.5 0.5
Loa Loa (eye worm) animal heme peroxidase 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Onchocerca volvulus 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Brugia malayi Peroxidasin 0.0095 0.5 0.5
Onchocerca volvulus Chorion peroxidase homolog 0.0095 0.5 0.5
Schistosoma mansoni peroxidasin 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Brugia malayi Blistered cuticle protein 3 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Echinococcus granulosus peroxidasin 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0095 0.5 0.5
Echinococcus multilocularis peroxidasin 0.0095 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0095 0.5 0.5
Onchocerca volvulus Peroxidase homolog 0.0095 0.5 0.5
Onchocerca volvulus Peroxidase homolog 0.0095 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
Change (functional) = -37 % Percent change in average volume of pleural fluid at a dose of 100 mg/kg and 5-h response by Evans blue-carrageenan induced pleural effusion assay. ChEMBL. 6436487
Change (functional) = -36 % Percent change in average volume of pleural fluid at a dose 4 mg/kg of indomethacin and 5-h response is evaluated by Evans blue-carrageenan induced pleural effusion assay ChEMBL. 6436487
Change (functional) = -25 % Percent change in avgerage volume of pleural fluid at a dose of 4.0 mg/kg and 5-h response by Evans blue-carrageenan induced pleural effusion assay. ChEMBL. 6436487
ED50 (functional) = 0.19 mg kg-1 Oral analgesic activity was determined in mice by the acetylcholine-induced abdominal constriction assay upon ip administration of acetylcholine bromide 5 hours following oral administration ChEMBL. 6436487
ED50 (functional) = 0.19 mg kg-1 Oral analgesic activity was determined in mice by the acetylcholine-induced abdominal constriction assay upon ip administration of acetylcholine bromide 5 hours following oral administration ChEMBL. 6436487
ED50 (functional) = 0.66 mg kg-1 Oral analgesic activity was determined in mice by the acetylcholine-induced abdominal constriction assay upon ip administration of acetylcholine bromide 20 min following oral administration ChEMBL. 6436487
ED50 (functional) = 0.66 mg kg-1 Oral analgesic activity was determined in mice by the acetylcholine-induced abdominal constriction assay upon ip administration of acetylcholine bromide 20 min following oral administration ChEMBL. 6436487
Gastric toxicity (ADMET) = 1.2 Acute gastric toxicity (single oral dose) in male fasted rats ChEMBL. 6436487
IC50 (binding) = 0.05 uM Inhibition of prostaglandin G/H synthase obtained from bovine seminal vesicles. ChEMBL. 6436487
IC50 (binding) = 0.05 uM Inhibition of prostaglandin G/H synthase obtained from bovine seminal vesicles. ChEMBL. 6436487
Intestinal toxicity (ADMET) = 3.3 Evaluated for chronic intestinal toxicity (multiple oral dose) in rats ChEMBL. 6436487
Potency (functional) = 2.5 Evaluated for chronic potency in adjuvant arthritis assay ChEMBL. 6436487
Potency (functional) = 4.9 Evaluated for acute potency in pleural effusion assay ChEMBL. 6436487

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.